Nikhil Narang, MD
@Nikhil15
HF/Transplant/LVAD Cardiologist, Advocate Christ Medical Center @advocatehealth • @UCCardsfellows @MedChiefs alum • Dad • #JACCHF #SoMe Team @JACCJournals
ID:16662432
09-10-2008 05:06:05
3,2K Tweets
2,7K Followers
1,5K Following
Follow People
Andrew J Sauer MD
Cardiologist @MidAmericaHeart, proven program builder; to address unmet needs; focus on team-oriented innovations in heart failure therapies. Also: #wellness
Ryan J Tedford MD
Chief, Heart Failure; Med Director, Cardiac Transplant; Prof of Medicine & P. Gazes Chair @MUSChealth; Father and Husband; RV Centric Views and Hemodynamicist
James Januzzi Jr MD
Hutter Family Professor at Harvard and @MGHHeartHealth. Director of HF and Biomarker Trials @BaimInstitute. ACC Trustee. @RedSox team doc. Opinions are my own.
Anu Lala-Trindade
Mother/wife/daughter. ❤️ Function cardiologist. Deputy Editor @JCardFail. HF Fellowship PD @MountSinaiNYC; DCC for @NHLBI @CTSN16; pursuing #SelfAwareness
Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦
Cardiologist, ❤️🩹Expert in Women & Heart Disease, Prevention, Author 'Saving Women's Hearts’- Heals 💔 President of ASPC #earlyinterventionalist @CedarsSinai
Really love this perspective piece Journal of Cardiac Failure by Jeff Teuteberg #AnubodhVarshney
onlinejcf.com/article/S1071-…
Nir Uriel, MD MSc Andrew J Sauer MD Robert Mentz, MD Manreet Kanwar Eric Adler
🚨1st SHORE pub‼️ > 2k🫀transplants, dual non-invasive rejection surveillance with GEP & dd-cfDNA:
1. ⬆️yield for ACR over either test alone
2. ⬇️number of biopsies
3. Great survival and🫀LVEF
Kiran Khush JHLT The ISHLT American Society of Transplantation (AST) HFSA Nir Uriel, MD MSc
jhltonline.org/article/S1053-…
Not to be missed! Hemodynamics, hemodynamics & more hemodynamics! See y’all n Chicago! Mark Belkin Jon Grinstein MD Michele Esposito Steve Hsu Brian Houston MD Jennifer Cowger Mak Lab Nancy Sweitzer MDPhD Marat Fudim, MD MHS Patrick Sullivan Navin Kapur MUSC-CardiologyFellowshipPrograms CardioNerds
On-treatment analysis of #TRANSFORM_HF led by Mark Kittipibul MD now in European Society of Cardiology Journals #EJHF
Among patients adherent to randomized diuretic, no significant difference in outcomes w #torsemide vs #furosemide . Further supports message of original trial results.
onlinelibrary.wiley.com/doi/full/10.10…
Surveillance with Dual Non-invasive Testing for Acute Cellular Rejection After Heart Transplantation: Outcomes from the SHORE Registry - JHLT
jhltonline.org/article/S1053-…
Kiran Khush Jeff Teuteberg Shelley Hall Palak Shah #VanBakel Nir Uriel, MD MSc Ashwin R MUSC-CardiologyFellowshipPrograms
⁉️What would it like when #Heart_Failure care is 'outsourced' to help with med titration, follow up and prevention of HF hospitalizations
➡️ Now we have such data
sciencedirect.com/science/articl…
In follow up: There were decreases in systolic blood pressure -7 and↗️in HF meds Journal of Cardiac Failure
🎙️NEW #HeartFailure2024 #LBCT Interview 💫Dr Muthu Vaduganathan joins us to discuss findings from the study of four trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.
📽️Watch here👉 tinyurl.com/5cv6rh2u
📊 #HF events were strikingly modifiable and
ICYMI: Dr. Mikhail Kosiborod shares 🔑 insights from his #JACC LBCT paper, exploring #semaglutide 's impact on the #heartfailure biomarker, #NTproBNP , in patients with #obesity -related #HFpEF . Don't miss the video 👇
📄: bit.ly/4afmmof
#HeartFailure2024 Harlan Krumholz
Timing of Cardio-Kidney Protection With SGLT2 Inhibitor varies in trials
Herat failure benefits occur early
MACE events evident early
Cardiovascular deaths & kidney outcome benefits much later
ahajournals.org/doi/10.1161/CI…
Brendon Neuen Muthu Vaduganathan et al
Here are the primary results of #aficamten in NEJM
nejm.org/doi/full/10.10…
#HeartFailure2024 #CardioTwitter
Incredibly grateful to Harriette Van Spall, MD MPH to present #PACTHF 5yr update at #HeartFailure2024
🔑 findings:
🔴 5 year ☠ = 65% in ♂️ and ♀️ patients
🔴 💲were high, and driven by readmission
🔴 🚫 sex differences in outcomes/costs, but ⬆️ specialist care in ♂️, ⬆️ supportive care in ♀️
Dr BiykemBozkurt delivered an incredible talk on the 🫀- renal axis at #HeartFailure2024 :
📍 #Albuminuria predicts HF risk➡️Annual screening of #eGFR & #UACR in #Type2DM with/without #CKD
📍 #Finerenone is recommended to ⬇️ CV & kidney failure, prevent HF in #CKD & #DM
Important work led by Senthil Selvaraj, MD, MS, MA with fantastic coauthor team
Svati Shah scottdavidsolomon Duke Heart Duke Health
Senthil Selvaraj, MD, MS, MA on CV prognosis in older adults with amyloidogenic V142I variant based on analysis of 4 pooled registries
🔗risks modified by age but not sex
🔗HF hospital events driven by #HFrEF , not #HFpEF
#LBCT #HeartFailure2024 #Amyloid
#HeartFailure2024
HFA sim pub out now Journal of Cardiac Failure from Muthu Vaduganathan Carolyn Lam et al
Who’s ready for FineArts results?!
Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 Anu Lala-Trindade Andrew J Sauer MD Ryan J Tedford MD Nosheen Reza, MD Vanessa Blumer, MD, FACC Quentin Youmans, MD, MSc, FACC Shashank Sinha, MD, MSc, FACC, FAHA
Patient reported outcomes in HF
1. Better capture how our patients feel
2. Predict outcomes
3. Should be included as trial endpoints
#HFA Lisbon
Mikhail Kosiborod European Society of Cardiology
📱Prof #RudolphdeBoer in our session on #monitoring patients w #heartfailure .
📱Barriers to broad #implementation of #telemonitoring & #digital technologies include limited #interoperability , #access , #scaleability , #sustainability & #integration w clinical services
#HFA2024
We also propose a new criteria C-INEEDHELP that recognizes role of #cardiaccachexia as defining role in HF Dr Amanda Vest Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA Rebecca Cogswell
